(Total Views: 450)
Posted On: 08/19/2020 12:34:32 PM
Post# of 153988
Re: wolfof chaco #50589
“the focus is on reviewing the studies and protocols and does not mention reviewing results?”
The leronlimab trial for M2M COVID19 patients is considered a study, it’s a clinical study. The results from the trial will be considered for the Fast Track designation.
The leronlimab trial for M2M COVID19 patients is considered a study, it’s a clinical study. The results from the trial will be considered for the Fast Track designation.
(1)
(0)
